Cabiralizumab (Anti-CSF1R / M-CSFR / CD115)

Cabiralizumab (Anti-CSF1R / M-CSFR / CD115) is an monoclonal antibody (MAb) targeting CSF1R. It can be used in the research of rheumatoid arthritis (RA), melanoma, kidney cancer, or non-small cell lung cancer. MW :146.3 KD.

• Supplier: Selleck Chemicals
• Product #: A2644
• Sku #: A2644-1mg